The Current Ratio as of June 2026 (TTM) for Hansa Biopharma AB (publ) (HNSBF) is 3.63

According to Hansa Biopharma AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 3.63. This represents a change of 80.42% compared to the average of 2.01 of the last 4 quarters.

Hansa Biopharma AB (publ) (HNSBF) Historical Current Ratio (quarterly & annually)

How has HNSBF Current Ratio performed in the past?

The mean historical Current Ratio of Hansa Biopharma AB (publ) over the last ten years is 7.35. The current 3.63 Current Ratio has changed 4.84% with respect to the historical average. Over the past ten years (40 quarters), HNSBF's Current Ratio was at its highest in in the March 2019 quarter at 17.76. The Current Ratio was at its lowest in in the September 2025 quarter at 1.11.

Hansa Biopharma AB (publ) (HNSBF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Hansa Biopharma AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hansa Biopharma AB (publ) (HNSBF) Average Current Ratio

How has HNSBF Current Ratio performed in the past?

The current Current Ratio of Hansa Biopharma AB (publ) (HNSBF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hansa Biopharma AB (publ) (HNSBF) Current Ratio vs. Peers

How is HNSBF’s Current Ratio compared to its peers?

Hansa Biopharma AB (publ)’s Current Ratio is less than Silence Therapeutics plc (9.83), less than Transgene S.A. (9.62), less than Probi AB (publ) (6.94), greater than Cellectis S.A. (1.52), greater than Santhera Pharmaceuticals Holding AG (1.29), greater than Immutep Limited (2.97), greater than Genfit S.A. (2.00), greater than Frontage Holdings Corporation (1.33), greater than hVIVO plc (1.63), greater than Mayne Pharma Group Limited (1.33),

Build a custom stock screener for Hansa Biopharma AB (publ) (HNSBF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hansa Biopharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hansa Biopharma AB (publ) (HNSBF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hansa Biopharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.